United States: Blood tests might detect as many as half of carcinomas at a treatable stage later, reported the new study.
The seven-cancer MCED blood test could save more lives if performed annually or every other year, researchers reported in the May 8, 2018, issue of BMJ Open, as reported by HealthDay.
Annual and Biennial Testing Could Cut Deaths
“Both annual and biennial MCED screening intervals have the potential to avert deaths associated with late-stage cancers when used in addition to current guideline-based cancer screening,” concluded a research team led by Peter Sasieni, a professor of cancer epidemiology with Queen Mary University of London.
Researchers said that the blood test searches for several types of cancer-specific signals, such as DNA fragments that are released into the blood by tumors.
